{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:53:39Z","timestamp":1794351219595,"version":"4.9.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":771,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19MC1911000"],"award-info":[{"award-number":["19MC1911000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Natural Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1038\/s41379-020-0589-x","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T08:02:46Z","timestamp":1591344166000},"page":"2473-2482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas"],"prefix":"10.1016","volume":"33","author":[{"given":"Xiangjie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-7968","authenticated-orcid":false,"given":"Ke","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohong","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0589-x_bib1","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1016\/j.clbc.2018.02.012","article-title":"Triple negative apocrine carcinomas as a distinct subtype of triple negative breast cancer: a case-control study","volume":"18","author":"Meattini","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-020-0589-x_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/PAS.0000000000000671","article-title":"Pure apocrine carcinomas represent a clinicopathologically distinct androgen receptor-positive subset of triple-negative breast cancers","volume":"40","author":"Mills","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0589-x_bib3","series-title":"Breast tumours","first-page":"p. 131","article-title":"Carcinomas with apocrine differentiation. WHO classification of tumours editorial board","author":"Provenzano","year":"2019"},{"key":"10.1038\/s41379-020-0589-x_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/modpathol.2010.50","article-title":"EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast","volume":"23","author":"Vranic","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0589-x_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clbc.2012.11.004","article-title":"Immunohistochemically defined subtypes and outcome of apocrine breast cancer","volume":"13","author":"Dellapasqua","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/s41379-020-0589-x_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2016.39","article-title":"Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology","volume":"29","author":"Weisman","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0589-x_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-0589-x_bib8","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1038\/s41379-020-0589-x_bib9","unstructured":"Brogi E. Apocirne carcinoma. In: Hoda SA, Brogi E, Koerner FC, Rosen PP (editors) Rosen's Breast Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2014. p. 645\u201366."},{"key":"10.1038\/s41379-020-0589-x_bib10","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib11","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib13","unstructured":"Salgado R,\u00a0Loi S,\u00a0Denkert C,\u00a0Badve S,\u00a0Demaria S,\u00a0Adams S, et al. International immuno-oncology biomarker working group on breast cancer. 2018. https:\/\/www.tilsinbreastcancer.org\/."},{"key":"10.1038\/s41379-020-0589-x_bib14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1038\/s41379-020-0589-x_bib15","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","article-title":"GenVisR: genomic visualizations in R","volume":"32","author":"Skidmore","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-020-0589-x_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jclinpath-2018-205485","article-title":"Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast","volume":"72","author":"D'Arcy","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-020-0589-x_bib17","doi-asserted-by":"crossref","first-page":"24579","DOI":"10.18632\/oncotarget.15597","article-title":"Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0589-x_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1245\/s10434-014-3984-z","article-title":"Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer","volume":"22","author":"Choi","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.4280","article-title":"Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes","volume":"232","author":"Lehmann","year":"2014","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-0589-x_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"Shah","year":"2012","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0589-x_bib21","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1038\/s41379-020-0589-x_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrclinonc.2013.124","article-title":"Luminal breast cancer: from biology to treatment","volume":"10","author":"Ignatiadis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature14669","article-title":"PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours","volume":"525","author":"Koren","year":"2015","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0589-x_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-9048-0","article-title":"PIK3CA mutations in breast cancer are associated with poor outcome","volume":"96","author":"Li","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-020-0589-x_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Network","year":"2012","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0589-x_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/0008-5472.CAN-12-1726","article-title":"PIK3CA mutation H1047R is associated with response to PI3K\/AKT\/mTOR signaling pathway inhibitors in early-phase clinical trials","volume":"73","author":"Janku","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0589-x_bib27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.2014.56.2439","article-title":"Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial","volume":"33","author":"Pogue-Geile","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5668-3","article-title":"Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study","volume":"19","author":"Yi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1038\/s41379-020-0589-x_bib29","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Breast Cancer, Version 1; 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"10.1038\/s41379-020-0589-x_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0589-x_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0897-333","article-title":"Germline mutations in PTEN are present in Bannayan-Zonana syndrome","volume":"16","author":"Marsh","year":"1997","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0589-x_bib32","first-page":"1387","article-title":"Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression","volume":"34","author":"Kechagioglou","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1038\/s41379-020-0589-x_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2626","article-title":"Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations","volume":"12","author":"Banneau","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-020-0589-x_bib34","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/sj.onc.1201756","article-title":"PTEN mutations in gliomas and glioneuronal tumors","volume":"16","author":"Duerr","year":"1998","journal-title":"Oncogene"},{"key":"10.1038\/s41379-020-0589-x_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/bj20031839","article-title":"The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif","volume":"379","author":"Walker","year":"2004","journal-title":"Biochem J"},{"key":"10.1038\/s41379-020-0589-x_bib36","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1093\/hmg\/ddr337","article-title":"A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes","volume":"20","author":"Rodriguez-Escudero","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/s41379-020-0589-x_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-017-0438-7","article-title":"Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38\/07 prospective clinical trial cohort","volume":"10","author":"Juskevicius","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib38","first-page":"3254","article-title":"PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma","volume":"58","author":"Levine","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0589-x_bib39","doi-asserted-by":"crossref","first-page":"42198","DOI":"10.18632\/oncotarget.15030","article-title":"Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0589-x_bib40","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/humu.23288","article-title":"Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome","volume":"38","author":"Chen","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1038\/s41379-020-0589-x_bib41","first-page":"2636","article-title":"PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas","volume":"7","author":"Minaguchi","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0589-x_bib42","first-page":"475","article-title":"FGFR-TACC gene fusions in human glioma","volume":"19","author":"Lasorella","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","article-title":"The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing","volume":"22","author":"Helsten","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0589-x_bib44","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2159-8290.CD-13-0142","article-title":"An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)","volume":"3","author":"Korpal","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-020-0589-x_bib45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1158\/1535-7163.MCT-15-0892","article-title":"The Effect of F877L and T878A mutations on androgen receptor response to enzalutamide","volume":"15","author":"Prekovic","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/s41379-020-0589-x_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/annonc\/mdw067","article-title":"A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)","volume":"27","author":"Bonnefoi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0589-x_bib47","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2016.71.3495","article-title":"Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer","volume":"36","author":"Traina","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-0589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-0589-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-0589-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:34:37Z","timestamp":1760229277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222004185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0893395222004185"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0589-x","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0589-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}